- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/14 - Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Patent holdings for IPC class C07D 209/14
Total number of patents in this class: 845
10-year publication summary
|
62
|
72
|
44
|
62
|
42
|
44
|
50
|
52
|
39
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Achillion Pharmaceuticals, Inc. | 168 |
23 |
| Generics [UK] Limited | 129 |
20 |
| Katholieke Universiteit Leuven | 1111 |
20 |
| Janssen Pharmaceuticals, Inc. | 411 |
15 |
| Novartis AG | 11254 |
14 |
| Adeka Corporation | 1342 |
12 |
| Bristol-myers Squibb Company | 4863 |
11 |
| Pacific Biosciences of California, Inc. | 753 |
10 |
| Life Technologies Corporation | 3208 |
9 |
| The Board of Trustees of the University of Illinois | 2666 |
9 |
| Redwood BioScience, Inc. | 31 |
9 |
| Janssen Pharmaceutica N.V. | 3612 |
8 |
| The Johns Hopkins University | 5533 |
8 |
| Vertex Pharmaceuticals Incorporated | 1568 |
8 |
| Mylan Development Centre Private Limited | 12 |
8 |
| Rutgers, The State University of New Jersey | 1844 |
8 |
| Neoculi Pty Ltd | 18 |
7 |
| PMV Pharmaceuticals, Inc. | 38 |
7 |
| Bayer Schering Pharma AG | 429 |
6 |
| The General Hospital Corporation | 4650 |
6 |
| Other owners | 627 |